General Information
Drug ID
DR01378
Drug Name
99mTc-sestamibi
Synonyms
Sestamibi; RP-30; Tc-MIBI; Technetium-99m sestamibi
Drug Type
Small molecular drug
Indication Breast cancer [ICD11: 2C60-2C6Z] Approved [1]
Structure
3D MOL 2D MOL
Formula
C36H66N6O6Tc+7
Canonical SMILES
CC(C)(C[N+]#[C-])OC.CC(C)(C[N+]#[C-])OC.CC(C)(C[N+]#[C-])OC.CC(C)(C[N+]#[C-])OC.CC(C)(C[N+]#[C-])OC.CC(C)(C[N+]#[C-])OC.[Tc+7]
InChI
InChI=1S/6C6H11NO.Tc/c6*1-6(2,8-4)5-7-3;/h6*5H2,1-2,4H3;/q;;;;;;+7/i;;;;;;1+1
InChIKey
ZGDBEIODOXIKGQ-KTTJZPQESA-N
CAS Number
CAS 109581-73-9
Pharmaceutical Properties Molecular Weight 777.9 Topological Polar Surface Area 81.5
Heavy Atom Count 49 Rotatable Bond Count 12
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 12
PubChem CID
9832136
TTD Drug ID
D09BIW
DT(s) Transporting This Drug MRP1 Transporter Info Multidrug resistance-associated protein 1 Substrate [2]
References
1 99mTc-sestamibi was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein. Br J Cancer. 1998;77(3):353-8.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.